Real-world Tildrakizumab Effectiveness and Drug Survival: A Cohort Study in the PPD CorEvitas Psoriasis Registry.

Bagel J, Gogineni R, Shaikh A, Blachley T, Eckmann T, Beeghly A, Lebwohl MG

Open source

DOI
10.1007/s13555-026-01843-6
Published
2026 Sep
Container
Dermatology and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s13555-026-01843-6,
  title = {Real-world Tildrakizumab Effectiveness and Drug Survival: A Cohort Study in the PPD CorEvitas Psoriasis Registry.},
  author = {Bagel J and Gogineni R and Shaikh A and Blachley T and Eckmann T and Beeghly A and Lebwohl MG},
  year = {2026},
  journal = {Dermatology and therapy},
  doi = {10.1007/s13555-026-01843-6},
  url = {https://doi.org/10.1007/s13555-026-01843-6}
}

RIS

TY  - JOUR
TI  - Real-world Tildrakizumab Effectiveness and Drug Survival: A Cohort Study in the PPD CorEvitas Psoriasis Registry.
AU  - Bagel J
AU  - Gogineni R
AU  - Shaikh A
AU  - Blachley T
AU  - Eckmann T
AU  - Beeghly A
AU  - Lebwohl MG
PY  - 2026
JO  - Dermatology and therapy
DO  - 10.1007/s13555-026-01843-6
UR  - https://doi.org/10.1007/s13555-026-01843-6
ER  - 

APA

J, B., R, G., A, S., T, B., T, E., A, B., & MG, L. (2026). Real-world Tildrakizumab Effectiveness and Drug Survival: A Cohort Study in the PPD CorEvitas Psoriasis Registry.. Dermatology and therapy. https://doi.org/10.1007/s13555-026-01843-6

Source records